SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Holmes Biopharma, Inc. – ‘NT 10-Q’ for 9/30/01

On:  Thursday, 11/15/01   ·   For:  9/30/01   ·   Accession #:  1117768-1-500040   ·   File #:  0-31129

Previous ‘NT 10-Q’:  None   ·   Next:  ‘NT 10-Q’ on 5/15/03 for 3/31/03   ·   Latest:  ‘NT 10-Q’ on 8/14/08 for 6/30/08

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/15/01  Holmes Biopharma, Inc.            NT 10-Q     9/30/01    1:6K                                     123EDGARDIRECT Inc/FA

Notice of a Late Filing of a Form 10-Q   —   Form 12b-25
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NT 10-Q     Notice of a Late Filing of a Form 10-Q              HTML      9K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  late  

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 12b-25

Commission File Number 000-31129

NOTIFICATION OF LATE FILING

(Check One:) __ Form 10-K __ Form 11-K __ Form 20-F X Form 10-Q

Form N-SAR

For Period Ended: September 30, 2001

Transition Report on Form 10-K Transition Report on Form 10-Q
Transition Report on Form 20-F Transition Report on Form N-SAR
Transition Report on Form 11-K

For the Transition Period Ended: ________________________________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I

REGISTRANT INFORMATION

Full name of registrant: HOLMES HERBS INC.

Former name if applicable:

Address of principal executive office: Tundra Group HSE, 8275 South Eastern Avenue, Las Vegas, Nevada 89123

PART II

RULE 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 

 

 

 

 

 

 

 

x

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

(b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached, if applicable.

PART III

NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period. (Attach extra sheets if needed.)

Auditor has not completed the financial statements for the Company to date and further time is needed.

 

PART IV

OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification:

 

Donald Haines (702) 938-0460
(Name) (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registration was required to file such report(s) been filed? If the answer is no, identify report(s).

x Yes No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes x No

 

 

 

If so: attach an explanation of the anticipated change, both narratively and quantitatively and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

HOLMES HERBS INC.

(Name of Registrant Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 15, 2001 By: /s/ Donald Haines_________
Donald Haines, President


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘NT 10-Q’ Filing    Date    Other Filings
Filed on:11/15/01
For Period End:9/30/0110QSB
 List all Filings 
Top
Filing Submission 0001117768-01-500040   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2020 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Oct. 27, 11:05:40.0am ET